难治性幽门螺杆菌感染,难在哪里?  

Refractory Helicobacter pylori infection,why refractory?

作　　者：谢川[1] 吕农华[1] XIE Chuan;LYU Nong-hua(Department of Gastroenterology,the First Affiliated Hospital of Nanchang University,Nanchang 330006,China)

机构地区：[1]南昌大学第一附属医院消化内科,江西南昌330006

出　　处：《中国实用内科杂志》2023年第4期269-271,共3页Chinese Journal of Practical Internal Medicine

基　　金：国家自然科学基金(81960112,82100599);江西省主要学科学术和科技带头人培养计划(20204BCJ23022);江西省杰出青年基金(20212ACB216003)。

摘　　要：难治性幽门螺杆菌(Helicobacter pylori,Hp)感染是目前临床医生面临的重要难题。新近发表的国内外共识对难治性Hp感染均给予了重点关注。为了更好的帮助临床医生认识和应对难治性Hp感染,文章将重点阐述我国Hp感染耐药和治疗现状,并进一步分析难治性Hp感染的原因,介绍难治性Hp感染的处理原则。Refractory Helicobacter pylori(Hp)infection is currently an important problem for clinicians.Recently published domestic and foreign consensuses have focused on refractory Hp infection.In order to better help clinicians understand and deal with refractory Hp infection,this article will focus on the current status of drug resistance and treatment of Hp infection in China,further analyze the causes of refractory Hp infection,and introduce the management principles for refractory Hp infection.

关 键 词：难治 幽门螺杆菌 感染 处理原则 

分 类 号：R573[医药卫生—消化系统]